Metraipolis › archive › dc_c48ffe488737
Peripheral Immune Modulation in Atopic Dermatitis During Dupilumab or Baricitinib Treatment Is Limited, as Assessed by Proteomic, Transcriptomic, and Torque… — Europe PMC PMID:42794489
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42794489
- DOI
- 10.3390/ijms27188056
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T18:15:20.014Z
- SHA-256 of the archived text
f76945b3e07f782b40918c56863c05da374220e73fbb55b56554e32e70b9b9c4- Stable URL of this page
https://metraipolis.com/documento/dc_c48ffe488737
How to cite
Peripheral Immune Modulation in Atopic Dermatitis During Dupilumab or Baricitinib Treatment Is Limited, as Assessed by Proteomic, Transcriptomic, and Torque… — Europe PMC PMID:42794489 — Europe PMC (en), https://europepmc.org/article/MED/42794489 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c48ffe488737 (Metraipolis archive dc_c48ffe488737, sha256 f76945b3e07f782b40918c56863c05da374220e73fbb55b56554e32e70b9b9c4)
BibTeX
@misc{dcc48ffe488737,
title = {Peripheral Immune Modulation in Atopic Dermatitis During Dupilumab or Baricitinib Treatment Is Limited, as Assessed by Proteomic, Transcriptomic, and Torque… — Europe PMC PMID:42794489},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42794489},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c48ffe488737; sha256 f76945b3e07f782b40918c56863c05da374220e73fbb55b56554e32e70b9b9c4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794489. Agents can read the archived copy with the MCP tool read_document.